Zhejiang Medicine Statistics

Total Valuation

Zhejiang Medicine has a market cap or net worth of CNY 15.35 billion. The enterprise value is 14.40 billion.

Market Cap	15.35B
Enterprise Value	14.40B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jul 10, 2024

Share Statistics

Zhejiang Medicine has 961.64 million shares outstanding. The number of shares has decreased by -2.50% in one year.

Current Share Class	n/a
Shares Outstanding	961.64M
Shares Change (YoY)	-2.50%
Shares Change (QoQ)	+6.79%
Owned by Insiders (%)	0.34%
Owned by Institutions (%)	5.98%
Float	581.82M

Valuation Ratios

The trailing PE ratio is 15.60 and the forward PE ratio is 11.06.

PE Ratio	15.60
Forward PE	11.06
PS Ratio	1.69
PB Ratio	1.48
P/TBV Ratio	n/a
P/FCF Ratio	54.24
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.50, with an EV/FCF ratio of 50.90.

EV / Earnings	14.73
EV / Sales	1.59
EV / EBITDA	10.50
EV / EBIT	19.75
EV / FCF	50.90

Financial Position

The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.07.

Current Ratio	2.61
Quick Ratio	1.70
Debt / Equity	0.07
Debt / EBITDA	0.55
Debt / FCF	2.65
Interest Coverage	25.58

Financial Efficiency

Return on equity (ROE) is 8.33% and return on invested capital (ROIC) is 4.13%.

Return on Equity (ROE)	8.33%
Return on Assets (ROA)	3.50%
Return on Capital (ROIC)	4.13%
Revenue Per Employee	1.45M
Profits Per Employee	157,050
Employee Count	6,227
Asset Turnover	0.69
Inventory Turnover	2.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +42.76% in the last 52 weeks. The beta is 0.08, so Zhejiang Medicine's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	+42.76%
50-Day Moving Average	16.33
200-Day Moving Average	12.29
Relative Strength Index (RSI)	39.51
Average Volume (20 Days)	39,987,659

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Zhejiang Medicine had revenue of CNY 9.03 billion and earned 977.95 million in profits. Earnings per share was 1.02.

Revenue	9.03B
Gross Profit	3.28B
Operating Income	729.03M
Pretax Income	1.03B
Net Income	977.95M
EBITDA	1.37B
EBIT	729.03M
Earnings Per Share (EPS)	1.02

Full Income Statement

Balance Sheet

The company has 1.96 billion in cash and 749.73 million in debt, giving a net cash position of 1.21 billion or 1.26 per share.

Cash & Cash Equivalents	1.96B
Total Debt	749.73M
Net Cash	1.21B
Net Cash Per Share	1.26
Equity (Book Value)	10.61B
Book Value Per Share	10.75
Working Capital	3.79B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 915.67 million and capital expenditures -632.71 million, giving a free cash flow of 282.96 million.

Operating Cash Flow	915.67M
Capital Expenditures	-632.71M
Free Cash Flow	282.96M
FCF Per Share	0.29

Full Cash Flow Statement

Margins

Gross margin is 36.30%, with operating and profit margins of 8.07% and 10.83%.

Gross Margin	36.30%
Operating Margin	8.07%
Pretax Margin	11.36%
Profit Margin	10.83%
EBITDA Margin	15.18%
EBIT Margin	8.07%
FCF Margin	3.13%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 0.94%.

Dividend Per Share	0.15
Dividend Yield	0.94%
Dividend Growth (YoY)	-11.76%
Years of Dividend Growth	n/a
Payout Ratio	17.48%
Buyback Yield	2.50%
Shareholder Yield	3.44%
Earnings Yield	6.41%
FCF Yield	1.84%

Dividend Details

Stock Splits

The last stock split was on October 9, 2013. It was a forward split with a ratio of 1.8.

Last Split Date	Oct 9, 2013
Split Type	Forward
Split Ratio	1.8

Scores

Zhejiang Medicine has an Altman Z-Score of 4.24.

Altman Z-Score	4.24
Piotroski F-Score	n/a